Item Type | Name |
Academic Article
|
Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers.
|
Academic Article
|
Efficacy of sequential annual vaccination with inactivated influenza virus vaccine.
|
Academic Article
|
Influenza: its control in persons and populations.
|
Academic Article
|
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.
|
Academic Article
|
Genetic approaches to attenuation of influenza A viruses for man.
|
Academic Article
|
Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein.
|
Academic Article
|
Comparison of trivalent cold-adapted recombinant (CR) influenza virus vaccine with monovalent CR vaccines in healthy unselected adults.
|
Academic Article
|
Comparison of US inactivated split-virus and Russian live attenuated, cold-adapted trivalent influenza vaccines in Russian schoolchildren.
|
Academic Article
|
Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans.
|
Academic Article
|
Increasing doses of purified influenza virus hemagglutinin and subvirion vaccines enhance antibody responses in the elderly.
|
Academic Article
|
Cytotoxic T lymphocyte responses of infants after natural infection or immunization with live cold-recombinant or inactivated influenza A virus vaccine.
|
Academic Article
|
Variability in infectivity of cold-adapted recombinant influenza virus vaccines in humans.
|
Academic Article
|
Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults.
|
Academic Article
|
Influenza: prospects for control.
|
Academic Article
|
First International Symposium on Influenza and Other Respiratory Viruses: summary and overview: Kapalua, Maui, Hawaii, December 4-6, 1998.
|
Academic Article
|
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.
|
Academic Article
|
Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
|
Academic Article
|
Measures for control of influenza.
|
Academic Article
|
Prevention and treatment of influenza.
|
Academic Article
|
Estimating deaths due to influenza and respiratory syncytial virus.
|
Academic Article
|
Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy.
|
Academic Article
|
Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults.
|
Academic Article
|
Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations.
|
Academic Article
|
Evaluations for in vitro correlates of immunogenicity of inactivated influenza a H5, H7 and H9 vaccines in humans.
|
Academic Article
|
Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons.
|
Academic Article
|
A dose-response evaluation of inactivated influenza vaccine given intranasally and intramuscularly to healthy young adults.
|
Academic Article
|
Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses.
|
Academic Article
|
Humoral and cell-mediated immune responses of humans to inactivated influenza vaccine with or without QS21 adjuvant.
|
Academic Article
|
Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects.
|
Academic Article
|
Seasonal inactivated influenza virus vaccines.
|
Academic Article
|
Contrasting effects of type I interferon as a mucosal adjuvant for influenza vaccine in mice and humans.
|
Academic Article
|
A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects.
|
Academic Article
|
Live attenuated and inactivated influenza vaccine in school-age children.
|
Academic Article
|
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine.
|
Academic Article
|
Early patterns of gene expression correlate with the humoral immune response to influenza vaccination in humans.
|
Academic Article
|
A randomized clinical trial of an inactivated avian influenza A (H7N7) vaccine.
|
Academic Article
|
A polysaccharide-protein complex from Haemophilus influenzae type b. III. Vaccine trial in human adults.
|
Academic Article
|
High doses of purified influenza A virus hemagglutinin significantly augment serum and nasal secretion antibody responses in healthy young adults.
|
Academic Article
|
Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant.
|
Academic Article
|
Advances in influenza virus vaccine research.
|
Academic Article
|
Improvement of inactivated influenza virus vaccines.
|
Academic Article
|
Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma.
|
Academic Article
|
Increasing doses of an inactivated influenza A/H1N1 vaccine induce increasing levels of cross-reacting antibody to subsequent, antigenically different, variants.
|
Academic Article
|
Cold recombinant influenza B/Texas/1/84 vaccine virus (CRB 87): attenuation, immunogenicity, and efficacy against homotypic challenge.
|
Academic Article
|
Effect of live attenuated, cold recombinant (CR) influenza virus vaccines on pulmonary function in healthy and asthmatic adults.
|
Academic Article
|
Vaccination with inactivated influenza A virus during pregnancy protects neonatal mice against lethal challenge by influenza A viruses representing three subtypes.
|
Academic Article
|
Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus.
|
Academic Article
|
Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines.
|
Concept
|
Vaccines, Inactivated
|
Concept
|
Vaccines
|
Concept
|
Vaccines, Attenuated
|
Concept
|
Viral Hepatitis Vaccines
|
Concept
|
Viral Vaccines
|
Concept
|
Vaccines, Synthetic
|
Concept
|
Influenza Vaccines
|
Concept
|
Bacterial Vaccines
|
Concept
|
Hepatitis B Vaccines
|
Academic Article
|
Integrative genomic analysis of the human immune response to influenza vaccination.
|
Academic Article
|
Superior antigen-specific CD4+ T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older.
|
Academic Article
|
Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease.
|
Academic Article
|
Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus.
|
Grant
|
Viral Respiratory Pathogens Research Unit
|
Grant
|
Viral Respiratory Pathogens Research Unit
|
Grant
|
Viral Respiratory Pathogens Research Unit
|
Grant
|
Viral Respiratory Pathogens Research Unit
|
Grant
|
Viral Respiratory Pathogens Research Unit
|
Grant
|
EVALUATION OF INFECTIOUS DISEASE CONTROL
|
Grant
|
Viral Respiratory Pathogens Research Unit
|
Academic Article
|
The immunizing effect of influenza A/New Jersey/76 (Hsw1N1) virus vaccine administered intradermally and intramuscularly to adults.
|
Academic Article
|
Parenteral inactivated rhinovirus vaccine: minimal protective effect.
|
Academic Article
|
Antigenicity of licensed whole virion and subvirion influenza vaccines in "high risk" persons.
|
Academic Article
|
Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy.
|
Academic Article
|
The common cold: control?
|
Academic Article
|
Effect of influenza anti-neuraminidase antibody on virus neutralization.
|
Academic Article
|
An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers.
|
Academic Article
|
Variant-specific antihemagglutinin serum response to type A influenza natural infection and inactivated vaccines in adults.
|
Academic Article
|
Influenza--promising new developments.
|
Academic Article
|
Managing influenza in older patients.
|
Academic Article
|
Cell cytotoxicity due to specific influenza antibody production in vitro after recent influenza antigen stimulation.
|
Academic Article
|
Correlated studies of a recombinant influenza-virus vaccine. 3. Protection against experimental influenza in man.
|
Academic Article
|
Effects of tetracycline on leukotaxis.
|
Academic Article
|
Persistence of antibody to envelope antigens of Heq2Neq2 virus in ponies after infection and vaccination.
|
Academic Article
|
Live influenza A/Victoria/75 (H3N2) virus vaccines: reactogenicity, immunogenicity, and protection against wild-type virus challenge.
|
Academic Article
|
Lymphocyte cytotoxicity to influenza virus-infected cells: response to vaccination and virus infection.
|
Academic Article
|
Attenuation of rhinovirus type 15 for humans.
|
Academic Article
|
Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine.
|
Academic Article
|
INFECTION WITH ARTIFICIALLY PROPAGATED EATON AGENT (MYCOPLASMA PNEUMONIAE). IMPLICATIONS FOR DEVELOPMENT OF ATTENUATED VACCINE FOR COLD AGGLUTININ-POSITIVE PNEUMONIA.
|
Academic Article
|
Efficacy of purified influenza subunit vaccines and relation to the major antigenic determinants on the hemagglutinin molecule.
|
Academic Article
|
Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.
|
Academic Article
|
Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.
|
Academic Article
|
Influenza virus subunit vaccines. II. Immunogenicity and original antigenic sin in humans.
|
Academic Article
|
Influenza, influenza virus vaccine, and human immunodeficiency virus infection.
|
Academic Article
|
Antibody to Mycoplasma pneumoniae in nasal secretions and sputa of experimentally infected human volunteers.
|
Academic Article
|
Induction of partial immunity to influenza by a neuraminidase-specific vaccine.
|
Academic Article
|
Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004.
|
Academic Article
|
The leukocyte response during viral respiratory illness in man.
|
Academic Article
|
Influenza immunization.
|
Academic Article
|
Induction of immunity in man by crystalline adenovirus type 5 capsid antigens.
|
Academic Article
|
Intranasal influenza vaccine: adding to the armamentarium for influenza control.
|
Academic Article
|
Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology.
|
Academic Article
|
An outbreak of an influenza type A variant in a closed population: The effect of homologous and heterologous antibody on infection and illness.
|
Academic Article
|
Antigenicity of alum and aqueous adenovirus hexon antigen vaccines in man.
|